Loss M et al. |
Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients. |
1995 |
Transplant. Proc. |
pmid:7533365
|
Senninger N et al. |
Glucose metabolism following liver transplantation and immunosuppression with cyclosporine A or FK 506. |
1995 |
Transplant. Proc. |
pmid:7533364
|
Mor E et al. |
Weight gain and lipid profile changes in liver transplant recipients: long-term results of the American FK506 Multicenter Study. |
1995 |
Transplant. Proc. |
pmid:7533363
|
Söderdahl G et al. |
FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man. |
1995 |
Transplant. Proc. |
pmid:7533362
|
Bäckman L et al. |
Whole-blood and plasma levels of FK 506 after liver transplantation: results from the US Multicenter Trial. FK506 Multicenter Study Group. |
1995 |
Transplant. Proc. |
pmid:7533361
|
Abouljoud MS et al. |
Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group. |
1995 |
Transplant. Proc. |
pmid:7533360
|
Mueller AR et al. |
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A. |
1995 |
Transplant. Proc. |
pmid:7533359
|
Porayko MK et al. |
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533358
|
Platz KP et al. |
OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection. |
1995 |
Transplant. Proc. |
pmid:7533357
|
Yasuhara M et al. |
Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations. |
1995 |
Transplant. Proc. |
pmid:7533356
|
Schwartz M et al. |
FK 506 in liver transplantation: correlation of whole blood levels with efficacy and toxicity. The US Multicenter FK 506 Dose Optimization. |
1995 |
Transplant. Proc. |
pmid:7533355
|
Rucay P et al. |
FK 506 as treatment of late acute rejection in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533354
|
Jain AB et al. |
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. |
1995 |
Transplant. Proc. |
pmid:7533353
|
McDiarmid SV et al. |
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. |
1995 |
Transplantation |
pmid:7533345
|
Cox KL et al. |
An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. |
1995 |
Transplantation |
pmid:7533344
|
Shapiro R et al. |
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. |
1995 |
Transplantation |
pmid:7533343
|
Cameron AM et al. |
Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7533300
|
Fruman DA et al. |
FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells. |
1995 |
Eur. J. Immunol. |
pmid:7533090
|
Ning YM and Sanchez ER |
Stabilization in vitro of the untransformed glucocorticoid receptor complex of S49 lymphocytes by the immunophilin ligand FK506. |
1995 |
J. Steroid Biochem. Mol. Biol. |
pmid:7532989
|
Morikawa K et al. |
Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7532933
|
Van Thiel DH et al. |
Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. |
1995 |
Am. J. Gastroenterol. |
pmid:7532912
|
Cao W et al. |
Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506. |
1995 |
Transplantation |
pmid:7532879
|
Surdacka E et al. |
[New immunosuppressive drugs in transplantation]. |
1994 |
Prz. Lek. |
pmid:7532870
|
Dawson VL et al. |
Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. |
1994 |
Neuropharmacology |
pmid:7532825
|
Wang CR et al. |
T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection. |
1995 |
J. Exp. Med. |
pmid:7532685
|
Venkataraman L et al. |
FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. |
1995 |
J. Exp. Med. |
pmid:7532676
|
Kawai M et al. |
Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts. |
1995 |
J. Immunol. |
pmid:7532665
|
Donnelly JG and Soldin SJ |
Partial characterization of a 52 kDa CsA/FK506/rapamycin binding protein. |
1994 |
Clin. Biochem. |
pmid:7532557
|
Murthy JN et al. |
Identification of a 14 kDa FK-506/rapamycin binding immunophilin from calf thymus. |
1994 |
Clin. Biochem. |
pmid:7532556
|
Shapiro R et al. |
A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy. |
1994 |
Clin Transplant |
pmid:7532475
|
Konishi M et al. |
Effects of FK506 on surface antigen expression by regenerating thymocytes after sublethal irradiation in the rat. |
1994 |
Thymus |
pmid:7532330
|
Wolter K et al. |
Interaction between FK 506 and clarithromycin in a renal transplant patient. |
1994 |
Eur. J. Clin. Pharmacol. |
pmid:7532134
|
Marx SO et al. |
Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. |
1995 |
Circ. Res. |
pmid:7532117
|
Ryffel B et al. |
Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin. |
1994 Nov-Dec |
Exp. Nephrol. |
pmid:7532090
|
McCauley J |
The nephrotoxicity of FK506 as compared with cyclosporine. |
1993 |
Curr. Opin. Nephrol. Hypertens. |
pmid:7532089
|
Cacciarelli TV et al. |
Influence of the timing of FK 506 (Tacrolimus) administration on recovery of renal function from warm ischemic injury in rats. |
1994 Oct-Dec |
ASAIO J. |
pmid:7532042
|
Richter A et al. |
Growth inhibitory effects of FK506 and cyclosporin A independent of inhibition of calcineurin. |
1995 |
Biochem. Pharmacol. |
pmid:7531976
|
Foster CA et al. |
Pharmacological modulation of endothelial cell-associated adhesion molecule expression: implications for future treatment of dermatological diseases. |
1994 |
J. Dermatol. |
pmid:7531725
|
Timerman AP et al. |
Characterization of an exchange reaction between soluble FKBP-12 and the FKBP.ryanodine receptor complex. Modulation by FKBP mutants deficient in peptidyl-prolyl isomerase activity. |
1995 |
J. Biol. Chem. |
pmid:7531689
|
Lemster BH et al. |
IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy. |
1995 |
Clin. Exp. Immunol. |
pmid:7531627
|
Sekigawa I et al. |
FK506 can inhibit apoptotic cell death induced by the HIV-1 envelope glycoprotein gp120. |
1994 |
AIDS |
pmid:7531458
|
Fukuzaki T et al. |
A protocol with FK 506 for inducing unresponsiveness to murine islet allografts. |
1995 |
Surgery |
pmid:7531371
|
Bennett WM et al. |
Nephrotoxicity of immunosuppressive drugs. |
1994 |
Miner Electrolyte Metab |
pmid:7531274
|
Chen TS et al. |
Microbial transformation of immunosuppressive compounds. IV. Hydroxylation and hemiketal formation of ascomycin (immunomycin) by Streptomyces sp. MA 6970 (ATCC No. 55281). |
1994 |
J. Antibiot. |
pmid:7531195
|
Whiting PH |
Acute and chronic nephrotoxicity associated with immunosuppressive drugs. |
1994 |
Curr. Opin. Nephrol. Hypertens. |
pmid:7531104
|
Borel JF and Baumann G |
Molecular mechanisms of immunosuppressive agents. |
1994 |
Bull. Mem. Acad. R. Med. Belg. |
pmid:7531051
|
Todo S et al. |
Abdominal multivisceral transplantation. |
1995 |
Transplantation |
pmid:7530873
|
Gruessner RW et al. |
A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation. |
1995 |
Transplantation |
pmid:7530871
|
Heeckt PF et al. |
Functional impairment of enteric smooth muscle and nerves caused by chronic intestinal allograft rejection regresses after FK506 rescue. |
1995 |
Transplantation |
pmid:7530870
|
Neuhaus P et al. |
Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience. |
1995 |
Transplantation |
pmid:7530868
|
Fruman DA et al. |
The complex of FK506-binding protein 12 and FK506 inhibits calcineurin phosphatase activity and IgE activation-induced cytokine transcripts, but not exocytosis, in mouse mast cells. |
1995 |
J. Immunol. |
pmid:7530743
|
Leach KL et al. |
A soluble binding assay for measuring 3H-FK506 binding to the hsp56 immunophilin. |
1994 |
J Immunoassay |
pmid:7530727
|
Tsuchida M et al. |
Effects of irradiation, glucocorticoid and FK506 on cell-surface antigen expression by rat thymocytes: a three-colour flow cytofluorometric analysis. |
1994 |
Immunology |
pmid:7530693
|
Karanam BV et al. |
FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4. |
1994 Sep-Oct |
Drug Metab. Dispos. |
pmid:7530623
|
Dawson TM et al. |
The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin. |
1994 |
Neuroscience |
pmid:7530348
|
Petros AM and Fesik SW |
Nuclear magnetic resonance methods for studying protein-ligand complexes. |
1994 |
Meth. Enzymol. |
pmid:7530321
|
Eng WK et al. |
The yeast FKS1 gene encodes a novel membrane protein, mutations in which confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent growth. |
1994 |
Gene |
pmid:7530227
|
Wera S et al. |
Rapamycin, FK506 and cyclosporin A inhibit human prolactin gene expression. |
1995 |
FEBS Lett. |
pmid:7530217
|
Zarnt T et al. |
Time-dependent inhibition of peptidylprolyl cis-trans-isomerases by FK506 is probably due to cis-trans isomerization of the inhibitor's imide bond. |
1995 |
Biochem. J. |
pmid:7529995
|
Shipston MJ et al. |
Glucocorticoid negative feedback in pituitary corticotropes. Pivotal role for calcineurin inhibition of adenylyl cyclase. |
1994 |
Ann. N. Y. Acad. Sci. |
pmid:7529975
|
Peattie DA et al. |
Three distinct messenger RNAs can encode the human immunosuppressant-binding protein FKBP12. |
1994 |
Gene |
pmid:7529739
|
Braun W et al. |
Three-dimensional structure and actions of immunosuppressants and their immunophilins. |
1995 |
FASEB J. |
pmid:7529736
|
Atcherson MM and Trifillis AL |
Cytotoxic effects of FK506 on human renal proximal tubule cells in culture. |
1994 |
In Vitro Cell. Dev. Biol. Anim. |
pmid:7529625
|
Clardy J |
The chemistry of signal transduction. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7529414
|
Alamartine E et al. |
In-vitro effects of cyclosporin A, FK506, 6-mercaptopurine, and prednisolone on lymphokine-activated killer cells. |
1994 |
Nephrol. Dial. Transplant. |
pmid:7529381
|
Morozumi K and Takeda A |
[Kidney disorders induced by immunosuppressive agents]. |
1994 |
Nippon Naika Gakkai Zasshi |
pmid:7529294
|
Burkhalter EL et al. |
Severe neurological complications following orthotopic liver transplantation in patients receiving FK 506 and prednisone. |
1994 |
J. Hepatol. |
pmid:7529272
|
Cardenas ME et al. |
Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands. |
1994 |
EMBO J. |
pmid:7529175
|
Kraus-Friedmann N and Feng L |
Reduction of ryanodine binding and cytosolic Ca2+ levels in liver by the immunosuppressant FK506. |
1994 |
Biochem. Pharmacol. |
pmid:7529023
|
Coghlan VM et al. |
Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. |
1995 |
Science |
pmid:7528941
|
Douglas CM et al. |
The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7528927
|
Sandborn WJ et al. |
Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue. |
1995 |
Hepatology |
pmid:7528712
|
Chaudhuri B et al. |
The interaction between the catalytic A subunit of calcineurin and its autoinhibitory domain, in the yeast two-hybrid system, is disrupted by cyclosporin A and FK506. |
1995 |
FEBS Lett. |
pmid:7528690
|
Klaus GG et al. |
Properties of mouse CD40. Ligation of CD40 activates B cells via a Ca(++)-dependent, FK506-sensitive pathway. |
1994 |
Eur. J. Immunol. |
pmid:7528676
|
Moudgil A et al. |
Inhibition of in vitro immunoglobulin production by a novel immunosuppressive drug brequinar sodium. |
1994 |
Transplant Sci |
pmid:7528627
|
Echigo Y et al. |
Effects of cyclosporine and tacrolimus (FK 506) on acute pancreatitis in mice. |
1995 |
Arch Surg |
pmid:7528496
|
Bennett WM et al. |
Nephrotoxicity of immunosuppressive drugs. |
1994 |
Nephrol. Dial. Transplant. |
pmid:7528363
|
Monfar M et al. |
Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. |
1995 |
Mol. Cell. Biol. |
pmid:7528328
|
Sugiyama E et al. |
FK506, an immunosuppressant, partially inhibits interleukin 6 production by adherent rheumatoid synovial cells. |
1994 |
J. Rheumatol. |
pmid:7528280
|
Hachida M et al. |
[The rescue effect of FK506 in refractory rejection after cardiac transplantation]. |
1994 |
Nihon Kyobu Geka Gakkai Zasshi |
pmid:7528255
|
Stan R et al. |
Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue. |
1994 |
J. Biol. Chem. |
pmid:7528205
|
Yli-Kauhaluoma J and Janda KD |
Twisted alpha-keto amides as transition-state analogues for acyl-transfer reactions: synthesis of the immunoconjugates. |
1994 |
Bioorg. Med. Chem. |
pmid:7528089
|
Suzuki S |
FK506 and deoxyspergualin: experimental studies and clinical applications. |
1994 |
Transpl. Immunol. |
pmid:7528087
|
Hossain M et al. |
Eosinophil viability-enhancing activity in mite-sensitive bronchial asthma. |
1994 |
Intern. Med. |
pmid:7528071
|
Yamamoto S and Kato R |
Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants. |
1994 |
J. Dermatol. Sci. |
pmid:7528050
|
Tanabe M et al. |
The influence of donor and recipient strains in isolated small bowel transplantation in rats. |
1994 |
Transplant. Proc. |
pmid:7527986
|
Mueller AR et al. |
Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease. |
1994 |
Transplant. Proc. |
pmid:7527984
|
Lemmens HP et al. |
Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis. |
1994 |
Transplant. Proc. |
pmid:7527983
|
Reggiani P et al. |
Conversion to rescue therapy with FK 506: data from eight liver transplant patients. |
1994 |
Transplant. Proc. |
pmid:7527982
|
Kinoshita I et al. |
Immunosuppression with FK 506 insures good success of myoblast transplantation in MDX mice. |
1994 |
Transplant. Proc. |
pmid:7527978
|
Asselin I et al. |
Polymerase chain reaction-based assay to assess the success of myoblast transplantation in mdx mice. |
1994 |
Transplant. Proc. |
pmid:7527970
|
Tsugita M et al. |
Hepatocytes or liver nonparenchymal cells plus FK 506 prolong liver xenograft survival. |
1994 |
Transplant. Proc. |
pmid:7527969
|
Ricordi C et al. |
Donor bone marrow cell infusion without recipient cytoablation induces acceptance of rat islet allografts. |
1994 |
Transplant. Proc. |
pmid:7527967
|
Ericzon BG |
Early graft function in liver transplantation patients. |
1994 |
Transplant. Proc. |
pmid:7527965
|
Morris R |
Modes of action of FK506, cyclosporin A, and rapamycin. |
1994 |
Transplant. Proc. |
pmid:7527964
|
Frei U and Wagner K |
Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy. |
1994 |
Transplant. Proc. |
pmid:7527963
|
Sewing KF |
Pharmacokinetics, dosing principles, and blood level monitoring of FK506. |
1994 |
Transplant. Proc. |
pmid:7527962
|
Neuhaus PJ |
Optimised first-line FK506-based protocols in liver transplantation: experience from the University Hospital Rudolf Virchow, Berlin. |
1994 |
Transplant. Proc. |
pmid:7527961
|
|
Reduced incidence of acute, refractory acute, and chronic rejection after liver transplantation with FK506-based immunosuppression. European FK506 Multicentre Liver Study Group. |
1994 |
Transplant. Proc. |
pmid:7527960
|
Candinas D et al. |
Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7527959
|